Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Name: Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
License: Public Domain

Candel Therapeutics, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

borderline resectable pancreatic adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 146463
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.